Testbiotech’s complaint on the placing on the EU market of oilseed rape MON88302
Parma, Italy
August 7, 2015
Scientific advice to the European Commission on the internal review submitted under Regulation (EC) No 1367/2006 on the application of the provisions of the Aarhus Convention against the Commission Implementing Decision 2015/687 to authorise genetically modified
Abstract:
Following a request of the European Commission, the European Food Safety Authority (EFSA) reviewed the scientific arguments raised by Testbiotech against the Commission Implementing Decision 2015/687 authorising the placing on the market of products containing, consisting of, or produced from oilseed rape MON88302. Testbiotech, together with eight other non-governmental organisations, argued that the risk assessment of oilseed rape MON88302 performed by the EFSA GMO Panel is inadequate and flawed. EFSA analysed each of the scientific arguments put forward in the technical background of Testbiotech’s complaint on oilseed rape MON88302, and concludes that none of these arguments reveal new information that would invalidate the previous risk assessment conclusions and risk management recommendations on oilseed rape MON88302 made by the GMO Panel. Therefore, EFSA considers that the previous GMO Panel risk assessment conclusions and risk management recommendations on oilseed rape MON88302 remain valid and applicable.
Summary:
Following a request of the European Commission, the European Food Safety Authority (EFSA) assessed the scientific content of the technical background of Testbiotech’s complaint on oilseed rape MON88302. In this complaint against the Commission Implementing Decision 2015/687 authorising the placing on the market of products containing, consisting of, or produced from oilseed rape MON88302, Testbiotech (supported by eight other non-governmental organisations) criticises the 2014 EFSA GMO Panel scientific opinion on oilseed rape MON88302, arguing that the risk assessment performed by the GMO Panel is inadequate and flawed.
EFSA analysed each of the scientific arguments put forward in the technical background of Testbiotech’s complaint on oilseed rape MON88302, and concludes that none of these arguments reveal new information that would invalidate the previous risk assessment conclusions and risk management recommendations on oilseed rape MON88302 made by the GMO Panel. Therefore, EFSA considers that the previous GMO Panel risk assessment conclusions and risk management recommendations on oilseed rape MON88302 remain valid and applicable.
More news from: European Union - European Food Safety Authority (EFSA)
Website: http://www.efsa.europa.eu Published: August 10, 2015 |
The news item on this page is copyright by the organization where it originated Fair use notice |